Epidemiology of chronic lymphocytic leukemia in Chilean and Amerindian population in Chile

References

• Anderson JR, Armitage JO, Weisenburger DD. Epidemiology of the non-Hodgkin’s lymphomas: distributions of the major subtypes differ by geographic locations. Non-Hodgkin’s lymphoma classification project. Ann Oncol. 1998;9(7):717–720.
   PubMed Web of Science ®Google Scholar
• Sant M, Allemani C, Tereanu C, et al. Incidence of hematologic malignancies in Europe by morphologic subtype: results of the HAEMACARE project. Blood. 2010;116(19):3724–3734.
   PubMed Web of Science ®Google Scholar
• Tamura K, Sawada H, Izumi Y, et al. Chronic lymphocytic leukemia (CLL) is rare, but the proportion of T-CLL is high in Japan. Eur J Haematol. 2001;67(3):152–157.
   PubMed Web of Science ®Google Scholar
• Chihara D, Ito H, Matsuda T, et al. Differences in incidence and trends of haematological malignancies in Japan and the United States. Br J Haematol. 2014;164(4):536–545.
   PubMed Web of Science ®Google Scholar
• Wu S-J, Huang S-Y, Lin C-T, et al. The incidence of chronic lymphocytic leukemia in Taiwan, 1986–2005: a distinct increasing trend with birth-cohort effect. Blood. 2010;116(22):4430–4435.
   PubMed Web of Science ®Google Scholar
• Lee SJ, Tien HF, Park HJ, et al. Gradual increase of chronic lymphocytic leukemia incidence in Korea, 1999–2010: comparison to plasma cell myeloma. Leuk Lymphoma. 2016;57(3):585–589.
   PubMed Web of Science ®Google Scholar
• Marquez ME, Deglesne PA, Lopez JL, et al. Unexpectedly high frequency of European parentage in Venezuelan patients with chronic lymphocytic leukemia. Leuk Lymphoma. 2012;53(2):235–241.
   PubMed Web of Science ®Google Scholar
• Stanganelli C, Travella A, Bezares R, et al. Immunoglobulin gene rearrangements and mutational status in Argentinian patients with chronic lymphocytic leukemia. Clin Lymphoma Myeloma Leuk. 2013;13(4):447–457.
   PubMed Web of Science ®Google Scholar
• Goncalves M, Rodrigues CA, Heidemarie IG, et al. Chronic lymphocytic leukemia in Brazil: a retrospective analysis of 1903 cases. Am J Hematol. 2017;92(8):E171–E173.
   PubMed Web of Science ®Google Scholar
• Moro I, Foren L, Guillermo C, et al. Primer registro nacional de leucemias. Paper presented at XI Uruguayan Hematology Congress; 2009 November 19–21; Punta del Este, Uruguay.
   Google Scholar
• Bianchi S, Moreno P, Landoni AI, et al. Immunoglobulin heavy chain V-D-J gene rearrangement and mutational status in Uruguayan patients with chronic lymphocytic leukemia. Leuk Lymphoma. 2010;51(11):2070–2078.
   PubMed Web of Science ®Google Scholar
• Ruiz-Argüelles GJ, Velázquez BM, Apreza-Molina MG, et al. Chronic lymphocytic leukemia is infrequent in Mexican mestizos. Int J Hematol. 1999;69:253–255.
   PubMed Web of Science ®Google Scholar
• Laurini J, Perry AM, Boilesen E, et al. Classification of non-Hodgkin lymphoma in Central and South America: a review of 1028 cases. Blood. 2012;120(24):4795–4801.
   PubMed Web of Science ®Google Scholar
• Cabrera ME, Marinov N, Guerra C, et al. Síndromes linfoproliferativos crónicos en Chile. Estudio prospectivo de 132 casos. Rev Méd Chile. 2003;131:291–298.
   PubMed Web of Science ®Google Scholar
• Cabrera ME, Martinez V, Nathwani BN, et al. Non-Hodgkin lymphoma in Chile: a review of 207 consecutive adult cases by a panel of five expert hematopathologists. Leuk Lymphoma. 2012;53(7):1311–1317.
   PubMed Web of Science ®Google Scholar
• Kawamata N, Moreilhon C, Saitoh T, et al. Genetic differences between Asian and Caucasian chronic lymphocytic leukemia. Int J Oncol. 2013;43(2):561–565.
   PubMed Web of Science ®Google Scholar
• Hernandez A, Arellano A, Cruz J, et al. Genetic susceptibility variants for chronic lymphocytic leukaemia in Mexican mestizos. Br J Haematol. 2015;169:899–911.
   PubMed Web of Science ®Google Scholar
• Bertin P, Risueño C, Meller C. Expression of immunoglobulin heavy chain variable genes in B-chronic lymphocytic leukemia. Ann N Y Acad Sci. 1995;764:474–477.
   PubMed Web of Science ®Google Scholar
• Hungria VTM, Chiattone C, Pavlovsky M, et al. Epidemiology of hematologic malignancies in real-world settings: findings from the hemato-oncology Latin America Observational Registry Study. J Glob Oncol. 2019;5:1–19.
   Web of Science ®Google Scholar
• Resultados Censo 2017. Instituto Nacional de Estadisticas. Chile.20. https://www.censo2017.cl.
   Google Scholar
• Hallek M, Cheson BC, Catovsky D, et al. iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL. Blood. 2018;131(25):2745–2760.
   PubMed Web of Science ®Google Scholar
• Matutes E, Attygalle A, Wotherspoon A, et al. Diagnostic issues in chronic lymphocytic leukaemia (CLL). Best Pract Res Clin Haematol. 2010;23(1):3–20.
   PubMed Web of Science ®Google Scholar
• Moreau EJ, Matutes E, A’Hern RP, et al. Improvement of the chronic lymphocytic leukemia scoring system with the monoclonal antibody SN8 (CD79b). Am J Clin Pathol. 1997;108(4):378–382.
   PubMed Web of Science ®Google Scholar
• Rawstron AC, Kreuzer KA, Soosapilla A, et al. Reproducible diagnosis of chronic lymphocytic leukemia by flow cytometry: an European Research Initiative on CLL (ERIC) & European Society for Clinical Cell Analysis (ESCCA) harmonization project. Cytometry. 2018;94(1):121–128.
   PubMedGoogle Scholar
• Oscier D, Else M, Matutes E, et al. The morphology of CLL revisited: the clinical significance of prolymphocytes and correlations with prognostic/molecular markers in the LRF CLL4 trial. Br J Haematol. 2016;174(5):767–775.
   PubMed Web of Science ®Google Scholar
• Rai KR. A critical analysis of staging in CLL. In: Gale RP, Rai KR, editors. Chronic lymphocytic leukemia: recent progress and future directions. New York (NY): Alan R. Liss; 1987. p. 253–264.
   Google Scholar
• Sharma S, Rai KR. Chronic lymphocytic leukemia (CLL) treatment: so many choices, such great options. Cancer. 2019;125(9):1432–1440.
   PubMed Web of Science ®Google Scholar
• Rothhammer F, Dillehay TD. The late Pleistocene colonization of South America: an interdisciplinary perspective. Ann Hum Genet. 2009;73(Pt 5):540–549.
   PubMedGoogle Scholar
• Reich D, Patterson N, Campbell D, et al. Reconstructing Native American population history. Nature. 2012;488(7411):370–374.
   PubMed Web of Science ®Google Scholar
• Homburger JR, Moreno-Estrada A, Gignoux CR, et al. Genomic insights into the ancestry and demographic history of South America. PLOS Genet. 2015;11(12):e1005602.
   PubMed Web of Science ®Google Scholar
• Fuentes M, Pulgar I, Gallo C, et al. Geografía génica de Chile. Distribución regional de los aportes genéticos americanos, europeos y africanos. Rev Méd Chile. 2014;142(3):281–289.
   PubMedGoogle Scholar
• Eyheramendy S, Martinez FI, Manevy F, et al. Genetic structure characterization of Chileans reflects historical immigration patterns. Nat Commun. 2015;6:6472.
   PubMed Web of Science ®Google Scholar
• Xu Z, Zhang J, Wu S, et al. Younger patients with chronic lymphocytic leukemia benefit from rituximab treatment: a single center study in China. Oncol Lett. 2013;5(4):1266–1272.
   PubMed Web of Science ®Google Scholar
• Jeon YW, Cho SG. Chronic lymphocytic leukemia: a clinical review including Korean cohorts. Korean J Intern Med. 2016;31(3):433–443.
   PubMed Web of Science ®Google Scholar
• World Bank Open Data from The World Bank.34. https://www.worldbank.org/en/home. Life expectancy at birth.
   Google Scholar
• Mora A, Bosch R, Cuellar C, et al. CD200 is a useful marker in the diagnosis of chronic lymphocytic leukemia. Cytometry. 2019;96(2):143–148.
   PubMedGoogle Scholar
• Guía Clínica 2010 Leucemia en personas de 15 años y más. 36. https://www.minsal.cl/portal/url/item/7221fa2ff9d5c9c5e04001011f016052.pdf.
   Google Scholar
• Lenartova A, Johannesen TB, Tjønnfjord GE. National trends in incidence and survival of chronic lymphocytic leukemia in Norway for 1953–2012: a systematic analysis of population-based data. Cancer Med. 2016;5(12):3588–3595.
   PubMed Web of Science ®Google Scholar
• Abrisqueta P, Pereira A, Rozman C, et al. Improving survival in patients with chronic lymphocytic leukemia (1980–2008): the Hospital Clinic of Barcelona experience. Blood. 2009;114(10):2044–2050.
   PubMed Web of Science ®Google Scholar
• Weide R, Feiten S, Chakupurakal G, et al. Survival improvement of patients with chronic lymphocytic leukemia (CLL) in routine care 1995–2017. Leuk Lymphoma. 2020;61(3):557–566.
   PubMed Web of Science ®Google Scholar
• Lee LJ, Toze CL, Huang SJT, Gillan TL, et al. Improved survival outcomes with the addition of rituximab to initial therapy for chronic lymphocytic leukemia: a comparative effectiveness analysis in the province of British Columbia, Canada. Leuk Lymphoma. 2018;59(6):1356–1363.
   PubMed Web of Science ®Google Scholar
• Pulte D, Castro FA, Jansen L, et al. Trends in survival of chronic lymphocytic leukemia patients in Germany and the USA in the first decade of the twenty-first century. J Hematol Oncol. 2016;9(1):2–8.
   PubMedGoogle Scholar
• Strati P, Parikh SA, Chaffee KG, et al. Relationship between co-morbidities at diagnosis, survival and ultimate cause of death in patients with chronic lymphocytic leukaemia (CLL): a prospective cohort study. Br J Haematol. 2017;178(3):394–402.
   PubMed Web of Science ®Google Scholar
• Kyasa MJ, Hazlett L, Parris RS, et al. Veterans with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) have a markedly increased rate of second malignancy, which is the most common cause of death. Leuk Lymphoma. 2004;45(3):507–513.
   PubMed Web of Science ®Google Scholar
• Liu W, Ji X, Song Y, et al. Improving survival of 3760 patients with lymphoma: Experience of an academic center over two decades. Cancer Med. 2020;9(11):3765–3774.
   PubMed Web of Science ®Google Scholar
• Wu SJ, Chiang CJ, Lin CT, et al. Improving but inferior survival in patients with chronic lymphocytic leukemia in Taiwan: a population-based study, 1990–2004. PLOS One. 2013;8(4):e62930.
   PubMed Web of Science ®Google Scholar
• Wu SJ, Lin CT, Agathangelidis A, et al. Distinct molecular genetics of chronic lymphocytic leukemia in Taiwan: clinical and pathogenetic implications. Haematologica. 2017;102(6):1085–1090.
   PubMed Web of Science ®Google Scholar